Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis

International Journal of Cancer

Volumn 137, Issue 12, 2015, Pages 2803-2814

  Zhang, Xuemei ^a,b,c   Ai, Feiyan ^a,c   Li, Xiayu ^a,c   She, Xiaoling ^d   Li, Nan ^a,c   Tang, Anliu ^a,c   Qin, Zailong ^a,b,c   Ye, Qiurong ^a,b,c   Tian, Li ^a,c   Li, Guiyuan ^a,b,c   Shen, Shourong ^a,c   Ma, Jian ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c Hunan Key Laboratory of Nonresolving Inflammation and Cancer   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

colorectal cancer; Id3; non resolving inflammation; S100A8; S100A9

Indexed keywords

CALGRANULIN A; CALGRANULIN B; INHIBITOR OF DIFFERENTIATION 3; PROTEIN KINASE B; PROTEIN P21; SMAD5 PROTEIN; IDB3 PROTEIN, MOUSE; INHIBITOR OF DIFFERENTIATION PROTEIN; S100A8 PROTEIN, MOUSE; S100A9 PROTEIN, MOUSE; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; COLITIS; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; S100A8 GENE; S100A9 GENE; TUMOR INVASION; UPREGULATION; ADENOCARCINOMA; ANIMAL; BAGG ALBINO MOUSE; CANCER TRANSPLANTATION; CELL CYCLE; CELL MOTION; COLORECTAL TUMOR; DISEASE COURSE; GENE EXPRESSION REGULATION; IMMUNOLOGY; LUNG TUMOR; METABOLISM; MIDDLE AGED; NUDE MOUSE; PATHOLOGY; PHYSIOLOGY; SECONDARY; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CALGRANULIN A; CALGRANULIN B; CARCINOGENESIS; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLITIS; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; LUNG NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; TRANSCRIPTOME;

EID: 84943665239     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29671     Document Type: Article

References (66)

1. Hanahan D, Weinberg RA., Hallmarks of cancer: the next generation. Cell 2011; 144: 646-74
2. Elinav E, Nowarski, R, Thaiss CA, et al., Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer 2013; 13: 759-71
3. Eaden JA, Abrams KR, Mayberry JF., The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-35
4. Tang A, Li, N, Li X, et al., Dynamic activation of the key pathways: linking colitis to colorectal cancer in a mouse model. Carcinogenesis 2012; 33: 375-83
5. Kerkhoff C, Klempt M, Sorg C., Novel insights into structure and function of MRP8 (S100A8) and MRP14 (S100A9). Biochim Biophys Acta 1998; 1448: 200-11
6. Hunter MJ, Chazin WJ., High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J Biol Chem 1998; 273: 12427-35
7. Schmid KW, Lugering, N, Stoll R, et al., Immunohistochemical demonstration of the calcium-binding proteins MRP8 and MRP14 and their heterodimer (27E10 antigen) in Crohn's disease. Hum Pathol 1995; 26: 334-7
8. Turovskaya O, Foell, D, Sinha P, et al., RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis. Carcinogenesis 2008; 29: 2035-43
9. Carrion M, Juarranz, Y, Martinez C, et al., IL-22/IL-22R1 axis and S100A8/A9 alarmins in human osteoarthritic and rheumatoid arthritis synovial fibroblasts. Rheumatology (Oxford) 2013; 52: 2177-86
10. Youssef P, Roth, J, Frosch M, et al., Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 1999; 26: 2523-8
11. Schonthaler HB, Guinea-Viniegra, J, Wculek SK, et al., S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity 2013; 39: 1171-81
12. Murray PJ., Obesity corrupts myelopoiesis. Cell Metab 2014; 19: 735-6
13. Gebhardt C, Nemeth, J, Angel P, et al., S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006; 72: 1622-31
14. Burke M, Choksawangkarn, W, Edwards N, et al., Exosomes from myeloid-derived suppressor cells carry biologically active proteins. J Proteome Res 2014; 13: 836-43
15. Parris TZ, Kovacs, A, Aziz L, et al., Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma. Int J Cancer 2014; 134: 1617-29
16. El-Rifai W, Moskaluk, CA, Abdrabbo MK, et al., Gastric cancers overexpress S100A calcium-binding proteins. Cancer Res 2002; 62: 6823-6
17. Ichikawa M, Williams, R, Wang L, et al., S100A8/A9 activate key genes and pathways in colon tumor progression. Mol Cancer Res 2011; 9: 133-48
18. Hermani A, Hess, J, De Servi B, et al., Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer. Clin Cancer Res 2005; 11: 5146-52
19. Grebhardt S, Muller-Decker K, Bestvater F, et al., Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo. J Cell Physiol 2014; 229: 661-71
20. Acharyya S, Oskarsson, T, Vanharanta S, et al., A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell 2012; 150: 165-78
21. O'Dwyer D, Ralton, LD, O'Shea A, et al., The proteomics of colorectal cancer: identification of a protein signature associated with prognosis. PLoS One 2011; 6: e27718
22. Fong S, Debs RJ, Desprez PY., Id genes and proteins as promising targets in cancer therapy. Trends Mol Med 2004; 10: 387-92
23. Lyden D, Young, AZ, Zagzag D, et al., Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 1999; 401: 670-7
24. Wilson JW, Deed, RW, Inoue T, et al., Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index. Cancer Res 2001; 61: 8803-10
25. Tsai CL, Tsai, CN, Lin CY, et al., Secreted stress-induced phosphoprotein 1 activates the ALK2-SMAD signaling pathways and promotes cell proliferation of ovarian cancer cells. Cell Rep 2012; 2: 283-93
26. Mern DS, Hasskarl J, Burwinkel B., Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells. Br J Cancer 2010; 103: 1237-44
27. Deleu S, Savonet, V, Behrends J, et al., Study of gene expression in thyrotropin-stimulated thyroid cells by cDNA expression array: ID3 transcription modulating factor as an early response protein and tumor marker in thyroid carcinomas. Exp Cell Res 2002; 279: 62-70
28. Tsuchiya T, Okaji, Y, Tsuno NH, et al., Targeting Id1 and Id3 inhibits peritoneal metastasis of gastric cancer. Cancer Sci 2005; 96: 784-90
29. Asirvatham AJ, Carey JP, Chaudhary J., ID1-, ID2-, and ID3-regulated gene expression in E2A positive or negative prostate cancer cells. Prostate 2007; 67: 1411-20
30. Mern DS, Hoppe-Seyler, K, Hoppe-Seyler F, et al., Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells. Breast Cancer Res Treat 2010; 124: 623-33
31. O'Brien CA, Kreso, A, Ryan P, et al., ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell 2012; 21: 777-92
32. Forrest ST, Barringhaus, KG, Perlegas D, et al., Intron retention generates a novel Id3 isoform that inhibits vascular lesion formation. J Biol Chem 2004; 279: 32897-903
33. Deliri H, Meller, N, Kadakkal A, et al., Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury. Arterioscler Thromb Vasc Biol 2011; 31: 110-6
34. Forrest ST, Taylor, AM, Sarembock IJ, et al., Phosphorylation regulates Id3 function in vascular smooth muscle cells. Circ Res 2004; 95: 557-9
35. Tanaka T, Kohno, H, Suzuki R, et al., A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003; 94: 965-73
36. Huang da W, Sherman BT, Lempicki RA., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009; 4: 44-57
37. Cooper HS, Murthy, SN, Shah RS, et al., Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-49
38. Valcz G, Patai, AV, Kalmár A, et al., Myofibroblast-derived SFRP1 as potential inhibitor of colorectal carcinoma field effect. PLoS One 2014; 9: e106143
39. Noble CL, Abbas, AR, Cornelius J, et al., Regional variation in gene expression in the healthy colon is dysregulated in ulcerative colitis. Gut 2008; 57: 1398-405
40. Hummerich L, Muller, R, Hess J, et al., Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development. Oncogene 2006; 25: 111-21
41. Hu SP, Harrison, C, Xu K, et al., Induction of the chemotactic S100 protein, CP-10, in monocyte/macrophages by lipopolysaccharide. Blood 1996; 87: 3919-28
42. Xu K, Geczy CL., IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000; 164: 4916-23
43. Xu K, Yen T, Geczy CL., Il-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 2001; 166: 6358-66
44. Fujiu K, Manabe I, Nagai R., Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. J Clin Invest 2011; 121: 3425-41
45. Ghavami S, Rashedi, I, Dattilo BM, et al., S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 2008; 83: 1484-92
46. Lasorella A, Benezra R, Iavarone A., The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer 2014; 14: 77-91
47. Jin X, Yin, J, Kim SH, et al., EGFR-AKT-Smad signaling promotes formation of glioma stem-like cells and tumor angiogenesis by ID3-driven cytokine induction. Cancer Res 2011; 71: 7125-34
48. Wahdan-Alaswad RS, Song, K, Krebs TL, et al., Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res 2010; 70: 9106-17
49. Gebhardt C, Breitenbach, U, Tuckermann JP, et al., Calgranulins S100A8 and S100A9 are negatively regulated by glucocorticoids in a c-Fos-dependent manner and overexpressed throughout skin carcinogenesis. Oncogene 2002; 21: 4266-76
50. Dale I, Fagerhol MK, Naesgaard I., Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983; 134: 6
51. Steinbakk M, Naess-Andresen, CF, Lingaas E, et al., Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990; 336: 763-5
52. Dhiman R, Venkatasubramanian, S, Paidipally P, et al., Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression. J Infect Dis 2014; 209: 578-87
53. Zindl CL, Lai, JF, Lee YK, et al., IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. Proc Natl Acad Sci USA 2013; 110: 12768-73
54. Moon A, Yong, HY, Song JI, et al., Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol Cancer Res 2008; 6: 1544-53
55. Kim HJ, Kang, HJ, Lee H, et al., Identification of S100A8 and S100A9 as serological markers for colorectal cancer. J Proteome Res 2009; 8: 1368-79
56. Goyette J, Geczy CL., Inflammation-associated S100 proteins: new mechanisms that regulate function. Amino Acids 2011; 41: 821-42
57. Lukanidin E, Sleeman JP., Building the niche: the role of the S100 proteins in metastatic growth. Semin Cancer Biol 2012; 22: 216-25
58. Hiratsuka S, Watanabe, A, Sakurai Y, et al., The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase. Nat Cell Biol 2008; 10: 1349-55
59. Ryckman C, Vandal, K, Rouleau P, et al., Proinflammatory activities of S100: proteins S100A8, S100A9, and S100A8/A9 induce neutrophil chemotaxis and adhesion. J Immunol 2003; 170: 3233-42
60. Vandal K, Rouleau, P, Boivin A, et al., Blockade of S100A8 and S100A9 suppresses neutrophil migration in response to lipopolysaccharide. J Immunol 2003; 171: 2602-9
61. Jin X, Sohn, YW, Yin J, et al., Blockade of EGFR signaling promotes glioma stem-like cell invasiveness by abolishing ID3-mediated inhibition of p27(KIP1) and MMP3 expression. Cancer Lett 2013; 328: 235-42
62. Hofmann MA, Drury, S, Fu C, et al., RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999; 97: 889-901
63. Kerkhoff C, Sorg, C, Tandon NN, et al., Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry 2001; 40: 241-8
64. Srikrishna G, Panneerselvam, K, Westphal V, et al., Two proteins modulating transendothelial migration of leukocytes recognize novel carboxylated glycans on endothelial cells. J Immunol 2001; 166: 4678-88
65. Vogl T, Tenbrock, K, Ludwig S, et al., Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007; 13: 1042-9
66. Hibino T, Sakaguchi, M, Miyamoto S, et al., S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis. Cancer Res 2013; 73: 172-83